Abstract:Background: Cancer cells have an imbalance in oxidation-reduction (redox) homeostasis. Understanding the precise mechanisms and the impact of the altered redox microenvironment on the immunologic reaction to tumors is limited. Methods: We isolated exosomes from ovarian cancer cells through ultracentrifuge and characterized by Western-blots and Nanoparticle Tracking Analysis. 2D, 3D-coculture tumor model, and 3D live cell imaging were used to study the interactions between tumor cells, macrophages and CD3 T cells in vitro. The role of exosomal miR-155-5p in tumor growth was evaluated in xenograft nude mice models and immune-competent mice models. Flow cytometry and flow sorting were used to determine the expression levels of miR-155-5p and PD-L1 in ascites and splenic macrophages, and the percentages of CD3 T cells subpopulations. Results: The elevation of reactive oxygen species (ROS) greatly downregulated exosomal miR-155-5p expression in tumor cells. Neutralization of ROS with N-acetyl-L-cysteine (NAC) increased the levels of miR-155-5p in tumor exosomes that were taken up by macrophages, leading to reduction of macrophage migration and tumor spheroid infiltration. We further found that programmed death ligand 1 (PD-L1) is a functional target of miR-155-5p. Co-culture of macrophages pre-treated with NAC-derived tumor exosomes or exosomal miR-155-5p with T-lymphocytes leading to an increased percentage of CD8+ T-lymphocyte and a decreased CD3+ T cell apoptosis through PD-L1 downregulation. Tumor growth in nude mice was delayed by treatment with NAC-derived tumor exosomes. Delivery of tumor exo-miR-155-5p in immune-intact mice suppressed ovarian cancer progression and macrophage infiltration, and activated CD8+ T cell function. It is of note that exo-miR-155-5p inhibited tumor growth more potently than the PD-L1 antibody, suggesting that in addition to PD-L1, other pathways may also be targeted by this approach. Conclusions: Our findings demonstrate a novel mechanism, ROS-induced down-regulation of miR-155-5p, by which tumors modulate the microenvironment that favors tumor growth. Understanding of the negative impact of ROS on the tumor immune response will improve current therapeutic strategies. Targeting miR-155-5p can be an alternative approach to prevent formation of an immunosuppressive TME through downregulation of PD-L1 and other immunosuppressive factors.

Selective Killing of Lung Cancer Cells by Mirna-506 Molecule Through Inhibiting NF-κB P65 to Evoke Reactive Oxygen Species Generation and P53 Activation

MicroRNA-499 Serves As a Sensitizer for Lung Cancer Cells to Radiotherapy by Inhibition of CK2α-mediated Phosphorylation of P65

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.

Mechanism Of Mir-512-5p To Promote Radiotherapy Sensitivity Of Lung Cancer By Targeting Sod2

MicroRNA-508-3p Regulates the Proliferation of Human Lung Cancer Cells by Targeting G1 to S Phase Transition 1 (GSPT1) Protein.

miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.

Mir-503-5p Confers Drug Resistance by Targeting PUMA in Colorectal Carcinoma

Mir-296 Promotes Colorectal Cancer Cells Growth Through Regulating Nf-Kappa B

Bio-Engineered MicroRNA-7 is Effective to Interfere with Akt3/p53 Axis and Suppress Human Non-Small Cell Lung Cancer

Upregulation of Mir‐675‐5p Induced by Lncrna H19 Was Associated with Tumor Progression and Development by Targeting Tumor Suppressor P53 in Non–small Cell Lung Cancer

P53/microrna-374B/akt1 Regulates Colorectal Cancer Cell Apoptosis in Response to DNA Damage.

Mir-381 Accelerates Apoptosis, and Inhibits Proliferation, Migration and Invasion Via PI3K/Akt Signaling Pathway by Targeting NOX4 in Non-Small Cell Lung Cancer Cells

P53-induced Mir-1249 Inhibits Tumor Growth, Metastasis, and Angiogenesis by Targeting VEGFA and HMGA2

Mir-300 Regulates Cellular Radiosensitivity Through Targeting P53 and Apaf1 in Human Lung Cancer Cells

MiR-506 Suppresses Proliferation and Induces Senescence by Directly Targeting the CDK4/6-FOXM1 Axis in Ovarian Cancer.

Mir-512-5p Induces Apoptosis and Inhibits Glycolysis by Targeting P21 in Non-Small Cell Lung Cancer Cells

Negative regulation of tumor suppressor p53 by microRNA miR-504.

Mir-892b Silencing Activates Nf-Kappa B And Promotes Aggressiveness In Breast Cancer

Critical Role of Mir-155/Foxo1/ros Axis in the Regulation of Non-Small Cell Lung Carcinomas

Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway